<- Go Home
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Market Cap
EUR 27.2B
Volume
955.6K
Cash and Equivalents
EUR 2.4B
EBITDA
EUR 2.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 5.3B
Profit Margin
23.84%
52 Week High
EUR 50.74
52 Week Low
EUR 31.60
Dividend
2.07%
Price / Book Value
1.46
Price / Earnings
24.86
Price / Tangible Book Value
14.67
Enterprise Value
EUR 39.0B
Enterprise Value / EBITDA
13.54
Operating Income
EUR 1.8B
Return on Equity
5.89%
Return on Assets
2.61
Cash and Short Term Investments
EUR 2.4B
Debt
EUR 13.5B
Equity
EUR 19.3B
Revenue
EUR 22.4B
Unlevered FCF
EUR 1.7B
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium